PHASE I STUDY OF RUXOLITINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS AND GLIOBLASTOMA

被引:0
|
作者
Rauf, Yasmeen [1 ]
Hufsey, Rachel [2 ]
Robinson, Kathy [2 ]
Suh, John [2 ]
Chao, Samuel [2 ]
Murphy, Erin [2 ]
Yu, Jennifer [2 ]
Peereboom, David [2 ]
Ahluwalia, Manmeet [3 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CTNI-42
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [21] Phase I trial of vatalanib (PTK787) in combination with standard radiation and temozolomide in patients with newly diagnosed glioblastoma
    Batchelor, T.
    Eichler, A. F.
    Plotkin, S. R.
    Drappatz, J.
    Wen, P.
    Sorensen, A. G.
    Gerstner, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [23] AVASTIN AND TEMOZOLOMIDE FOLLOWING RADIATION AND CHEMOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PHASE II STUDY
    Nicholas, M. K.
    Chmura, S.
    Paleologos, Nina
    Krouwer, Hendrikus
    Malkin, Mark
    Junck, Larry
    Vick, Nicholas A.
    Lukas, Rimas V.
    NEURO-ONCOLOGY, 2011, 13 : 88 - 89
  • [24] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma
    Takeuchi, Satoru
    Wada, Kojiro
    Nagatani, Kimihiro
    Otani, Naoki
    Osada, Hideo
    Nawashiro, Hiroshi
    NEUROLOGY INDIA, 2014, 62 (01) : 42 - 47
  • [26] Serial evaluation of lymphocyte subsets in patients with newly diagnosed high grade gliomas treated with standard radiation and temozolomide
    Piotrowski, Anna F.
    Campian, Jian Li
    Hakim, Frances
    Rose, Jeremy
    Yan, Xiao-Yi
    Gress, Ronald
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] CYTOPENIAS IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS RECEIVING RADIATION AND TEMOZOLOMIDE-WHO IS AT RISK?
    Mrugala, M. M.
    Johnston, S. K.
    Chamberlain, M. C.
    San, J. V.
    Rockhill, J. K.
    Haug, J.
    Spence, A. M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1120 - 1120
  • [28] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [29] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [30] The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas
    Gerber, David E.
    Grossman, Stuart A.
    Zeltzman, Michel
    Parisi, Michele A.
    Kleinberg, Lawrence
    NEURO-ONCOLOGY, 2007, 9 (01) : 47 - 52